GlucoModicum's non-invasive CGM nears first filing

GlucoModicum's non-invasive CGM nears first filing

Finland's GlucoModicum thinks it is in the lead in the race to bring a non-invasive continuous glucose monitor (CGM) to market.

GlucoModicum has positive data for needle-free CGM

The needle-free CGM. [Image from GlucoModicum]GlucoModicum today announced positive outcomes from a clinical performance study of its needle-free continuous glucose monitor (CGM). Helsinki, Finland-based GlucoModicum said in a news release that the study helps put the company on “a clear path to commercialization.” The study involved 646 participant visits, including individuals with type 2 diabetes and healthy volunteers. The company says it re…